Repeat In-Laboratory Polysomnography is Required
In a patient with known OSA who used CPAP the day before a home sleep study showing nocturnal desaturation without obstructive events, you must obtain an in-laboratory polysomnography (PSG) to accurately diagnose the cause of desaturation and guide appropriate treatment. The home sleep study is invalid and cannot be used to make clinical decisions in this scenario.
Why the Home Sleep Study is Unreliable
The single day of CPAP use before testing creates a critical confounding variable. Research demonstrates that even brief CPAP therapy can alter upper airway physiology and respiratory patterns 1. When patients with restrictive chronic respiratory failure stop NIV, respiratory events begin immediately on the first night off therapy, with progressive nocturnal desaturation developing over subsequent nights 1. This same principle applies to OSA patients discontinuing CPAP—the acute withdrawal effects make interpretation of sleep studies unreliable.
Additionally, home sleep apnea testing (HSAT) has significant limitations in detecting non-obstructive causes of desaturation 2. The 2017 AASM guideline explicitly states that HSAT cannot distinguish between obstructive and central sleep apnea, and performs poorly in patients with comorbid conditions that cause nocturnal desaturation 2. In patients with heart failure, for example, HSAT had a specificity of only 0.17 for identifying central sleep apnea 2.
What the Nocturnal Desaturation Likely Represents
Several possibilities must be considered:
- Sleep hypoventilation (obesity hypoventilation syndrome, neuromuscular disease, COPD overlap)
- Central sleep apnea (treatment-emergent or complex sleep apnea from prior CPAP use)
- Residual obstructive events that HSAT failed to detect due to technical limitations
- Isolated nocturnal hypoxemia from underlying pulmonary disease 3
- Cardiac dysfunction causing Cheyne-Stokes respiration
Required Diagnostic Approach
Order attended in-laboratory PSG with full montage 4. This must include:
- Full EEG, EOG, chin and leg EMG
- Nasal pressure transducer and thermal airflow sensors
- Respiratory effort belts (thoracic and abdominal)
- Pulse oximetry
- End-tidal or transcutaneous CO₂ monitoring (critical for detecting hypoventilation)
- ECG
- Body position monitoring
The PSG should be performed after at least 2 weeks off CPAP to allow physiologic stabilization and avoid acute withdrawal effects 1. However, if the patient develops severe symptoms (morning headaches, worsening dyspnea, excessive daytime sleepiness), resume CPAP immediately and proceed with split-night PSG.
Why In-Laboratory PSG is Mandatory Here
The AASM guidelines are explicit: PSG is required when HSAT results are inconclusive or when non-obstructive sleep-disordered breathing is suspected 4. Your patient meets both criteria. The guideline specifically recommends PSG over HSAT for patients with:
- Suspected comorbid sleep disorders (central sleep apnea, hypoventilation)
- Significant cardiopulmonary disease
- Previous inconclusive or technically inadequate studies 2, 4
Furthermore, HSAT should not be used to rule out OSA 5. A negative or inconclusive HSAT in a patient with known OSA history and ongoing symptoms requires PSG confirmation.
Immediate Clinical Management
While awaiting PSG:
Resume CPAP therapy immediately at previous effective settings. The patient has documented OSA history, and discontinuing therapy risks cardiovascular events, accidents, and symptom recurrence 4.
Obtain daytime arterial blood gas (awake, room air). If PaO₂ <68 mmHg or PaCO₂ >45 mmHg, this predicts CPAP failure and indicates need for bilevel PAP or hypoventilation evaluation 6.
Check awake pulse oximetry. If SpO₂ ≥94%, CPAP is likely to be adequate; if <94%, consider empiric nocturnal oxygen supplementation pending PSG 6.
Screen for weight gain, new medications (opioids, benzodiazepines, gabapentinoids), or new cardiopulmonary diagnoses that could explain desaturation.
Common Pitfalls to Avoid
- Do not accept HSAT results as definitive when desaturation is present without corresponding respiratory events—this pattern demands PSG investigation 2
- Do not leave the patient off CPAP for extended periods while awaiting testing—this risks acute decompensation 1
- Do not add supplemental oxygen without PSG confirmation of the underlying disorder, as oxygen can worsen hypoventilation in some patients 7
- Do not assume the original OSA diagnosis is still accurate—patients can develop treatment-emergent central sleep apnea or progressive hypoventilation over time 4
The home study showing desaturation without obstructive events in a known OSA patient is a red flag requiring comprehensive attended PSG evaluation 2, 4.